571 related articles for article (PubMed ID: 19621015)
21. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.
Onozuka H; Nakajima A; Matsuzaki K; Shin RW; Ogino K; Saigusa D; Tetsu N; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
J Pharmacol Exp Ther; 2008 Sep; 326(3):739-44. PubMed ID: 18544674
[TBL] [Abstract][Full Text] [Related]
22. Wnt signaling in neuroprotection and stem cell differentiation.
Toledo EM; Colombres M; Inestrosa NC
Prog Neurobiol; 2008 Nov; 86(3):281-96. PubMed ID: 18786602
[TBL] [Abstract][Full Text] [Related]
23. Improving memory and decreasing cognitive impairment in Tg-APPswe/PSEN1dE9 mice with Aβ3-10 repeat fragment plasmid by reducing Aβ deposition and inflammatory response.
Ma Y; Li Y; Zong LX; Xing XN; Zhang WG; Cao YP
Brain Res; 2011 Jul; 1400():112-24. PubMed ID: 21658683
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.
Inestrosa NC; Godoy JA; Quintanilla RA; Koenig CS; Bronfman M
Exp Cell Res; 2005 Mar; 304(1):91-104. PubMed ID: 15707577
[TBL] [Abstract][Full Text] [Related]
25. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
26. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP
Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
[TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice.
Pedersen WA; McMillan PJ; Kulstad JJ; Leverenz JB; Craft S; Haynatzki GR
Exp Neurol; 2006 Jun; 199(2):265-73. PubMed ID: 16515786
[TBL] [Abstract][Full Text] [Related]
28. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
[TBL] [Abstract][Full Text] [Related]
29. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
30. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
31. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N
Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
Wirths O; Breyhan H; Marcello A; Cotel MC; Brück W; Bayer TA
Neurobiol Aging; 2010 May; 31(5):747-57. PubMed ID: 18657882
[TBL] [Abstract][Full Text] [Related]
33. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
34. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice.
Vodopivec I; Galichet A; Knobloch M; Bierhaus A; Heizmann CW; Nitsch RM
Neurodegener Dis; 2009; 6(5-6):270-80. PubMed ID: 20145420
[TBL] [Abstract][Full Text] [Related]
35. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
36. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
Pillay NS; Kellaway LA; Kotwal GJ
Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064
[TBL] [Abstract][Full Text] [Related]
37. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
[TBL] [Abstract][Full Text] [Related]
38. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
39. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
Arrázola MS; Varela-Nallar L; Colombres M; Toledo EM; Cruzat F; Pavez L; Assar R; Aravena A; González M; Montecino M; Maass A; Martínez S; Inestrosa NC
J Cell Physiol; 2009 Dec; 221(3):658-67. PubMed ID: 19711354
[TBL] [Abstract][Full Text] [Related]
40. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
